As the Director of Oncology at HCA Florida Ocala, I've witnessed firsthand how the combination of innovative technology and dedicated healthcare teams can transform patient outcomes. When we launched our high-risk women's program in 2023, I served as project manager, coordinating the implementation of the Ambry CARE Program® (CARE) across our …
We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …